Carregant...
CGRP-Based Migraine Therapeutics: How Might They Work, Why So Safe, and What Next?
[Image: see text] Migraine is a debilitating neurological condition that involves the neuropeptide calcitonin gene-related peptide (CGRP). An exciting development is the recent FDA approval of the first in an emerging class of CGRP-targeted drugs designed to prevent migraine. Yet despite this effica...
Guardat en:
| Publicat a: | ACS Pharmacol Transl Sci |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American
Chemical Society
2018
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6761833/ https://ncbi.nlm.nih.gov/pubmed/31559394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsptsci.8b00036 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|